Key Highlights

  • Aehr Test Systems' shares rose 27.86% to $98.91, reflecting strong investor sentiment.
  • For fiscal year 2026, Aehr reported revenue of $50 million, with a net loss of $7.1 million.
  • Backlog reached $80.6 million, highlighting strong demand and future revenue potential.

Aehr Test Systems (NASDAQ: AEHR) experienced a remarkable surge in share price, jumping 27.86% to close at $98.91. As investors capitalized on recent price drops, where shares fell to around $75, the substantial outlook drew renewed interest, pushing the market capitalization to approximately $3 billion. With a year-to-date performance showcasing a staggering 322.1% increase, Aehr Test Systems is clearly capturing the attention of market participants despite a recent downtrend over the past month.

By the Numbers

The latest figures from Aehr Test reveal a mixed financial performance amid the positive outlook. For the fiscal year 2026, the company generated revenue of $50 million, marking a decline of 15% from $59 million in the prior period. The net loss widened to $7.1 million, representing an 82% increase from the $3.9 million loss recorded in fiscal 2025.

However, the encouraging news comes from the fourth quarter, where the company reported a net income of $1.4 million, boosted by an increase in revenue to $18.8 million. The substantial half-year backlog at $80.6 million signals potential growth initiatives and revenue opportunities on the horizon, demonstrating a divergent trend from the previous fiscal year.

Segment Detail

Aehr Test's recent performance reflects a broader narrative of growth and operational efficiency despite challenges. The company's booking for the fourth quarter soared to a record $60.7 million, indicating a healthy and strong demand for its product offerings. As the sector transitions toward increased automation and precision in semiconductor testing, Aehr seems well-positioned to leverage its technology to create additional opportunities.

This achievement in bookings is critical, as it not only contributes to the backlog but also serves as a strong indicator of anticipated sales in the upcoming periods. The surge in demand underscores a favorable environment for Aehr in the booming semiconductor sector. This stark projection is informed not only by current backlog levels but also by elevated bookings, suggesting that demand for the company's services could outpace previous estimates.

As investors digest this guidance, many analysts view the company's trajectory favorably, with the potential to offset its recent net losses and utilize its increasing revenue to stabilize operations. Should the anticipated growth materialize, Aehr could significantly enhance its financial standing and market position.

Market Reaction

Following the optimistic outlook, Aehr Test shares saw a notable increase in pre-market trading, climbing 1.6% to $95.04. Volatility has characterized the stock, evidenced by a 52-week range spanning from $15.94 to $126.62. Despite a recent decline of 17.5% over the past month, the sheer increase in year-to-date performance speaks volumes, positioning Aehr Test as a highly attractive opportunity for both seasoned and new investors.

With 25 hedge funds collectively holding approximately $60.9 million in shares, there is significant institutional backing, further emphasizing the stock's potential given its rapidly evolving growth environment. Based on the company's Q4 results released in July 2026.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.